M&A: Private Equity Due Diligence on a Cybersecurity Firm

Commercial Due Diligence Questions:

1. Market Growth & Tailwinds: Is the shift to 'Zero Trust' a permanent architectural change or a passing fad? What are the regulatory drivers (e.g., HIPAA updates)?
2. Competitive Moat: Does the firm have proprietary IP or high switching costs? How easily can Microsoft or Palo Alto Networks replicate their specific healthcare features?
3. Cohort Analysis: What is the Net Revenue Retention (NRR)? Are healthcare providers expanding their usage over time, or just maintaining?

Healthcare Market Dynamics: It is both. The risk is a long sales cycle (12-18 months). The opportunity is 'stickiness.' Once a hospital integrates a security layer into its legacy EHR (Electronic Health Record) systems, they are extremely unlikely to switch, leading to very low churn.

Exit Strategy:

1. Strategic Acquisition: Sale to a major player (e.g., Cisco, Google Cloud) looking to bolster their healthcare vertical.
2. IPO: If the firm reaches >$200M ARR with a clear path to profitability.
3. Secondary Buyout: Sale to a larger PE firm specializing in late-stage software. Recommendation: Focus on aggressive sales expansion into the US Midwest and Europe to prove the model is scalable beyond a few 'lighthouse' clients.